Asker Healthcare Group revenue and financials
kr 66.30Change from previous close: −0.60%Absolute change: −kr 0.40
In the fiscal year ended December 2025, Asker Healthcare Group reported revenue of kr 16.79B (+11.73% year over year). Net income was kr 492M, a net margin of 2.9%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +11.73%
- 2025 vs 2024
- Net income growth
- +36.67%
- 2025 vs 2024
- Net margin
- 2.9%
- 2024: 2.4%
Financial data
Amounts in millions of SEK; per-share values in SEK; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 92.0 | 419 | 568 | 211 | 109 |
| Capital expenditure | -112 | -101 | -223 | -206 | -72.0 |
| Investing cash flow | -422 | -265 | -657 | -370 | -904 |
| Financing cash flow | 146 | -103 | 90.0 | 731 | 1,077 |
| Dividends paid | -149 | — | — | 0.0 | — |
| Share repurchases | — | — | — | -18.0 | — |
| Debt issued | 0.0 | 0.0 | 0.0 | 0.0 | 4,104 |
| Debt repaid | 0.0 | 0.0 | -100 | 0.0 | -4,037 |
| Effect of exchange rates | 15.0 | 11.0 | -23.0 | 18.0 | -37.0 |
| Net change in cash | -184 | 51.0 | 1.0 | 572 | 282 |
| Free cash flow | -20.0 | 318 | 345 | 5.0 | 37.0 |